Tactile Systems Technology (NASDAQ:TCMD – Get Rating) is set to issue its quarterly earnings data after the market closes on Monday, May 2nd. Analysts expect the company to announce earnings of ($0.31) per share for the quarter. Tactile Systems Technology has set its FY 2022 guidance at EPS.Investors interested in participating in the company’s conference call can do so using this link.
Tactile Systems Technology (NASDAQ:TCMD – Get Rating) last issued its quarterly earnings data on Tuesday, February 22nd. The company reported ($0.28) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.06 by ($0.34). Tactile Systems Technology had a negative return on equity of 7.31% and a negative net margin of 5.68%. The business had revenue of $61.73 million during the quarter, compared to the consensus estimate of $58.22 million. During the same quarter last year, the company earned $0.61 EPS. On average, analysts expect Tactile Systems Technology to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of NASDAQ:TCMD opened at $18.03 on Monday. The business has a 50 day simple moving average of $18.58. Tactile Systems Technology has a twelve month low of $13.37 and a twelve month high of $61.13. The company has a quick ratio of 2.74, a current ratio of 3.29 and a debt-to-equity ratio of 0.40. The company has a market cap of $359.27 million, a PE ratio of -30.05 and a beta of 1.37.
A number of equities analysts recently commented on TCMD shares. Zacks Investment Research raised Tactile Systems Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 11th. Piper Sandler dropped their price target on shares of Tactile Systems Technology from $40.00 to $28.00 in a research note on Wednesday, February 23rd. StockNews.com began coverage on shares of Tactile Systems Technology in a research note on Thursday, March 31st. They set a “hold” rating for the company. TheStreet lowered shares of Tactile Systems Technology from a “c-” rating to a “d” rating in a report on Wednesday, February 23rd. Finally, BTIG Research decreased their price objective on shares of Tactile Systems Technology from $44.00 to $29.00 in a report on Wednesday, February 23rd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Tactile Systems Technology currently has an average rating of “Buy” and an average price target of $38.00.
Large investors have recently bought and sold shares of the business. State Street Corp raised its position in shares of Tactile Systems Technology by 41.4% in the fourth quarter. State Street Corp now owns 1,077,933 shares of the company’s stock valued at $20,513,000 after buying an additional 315,539 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Tactile Systems Technology by 7.2% in the fourth quarter. BlackRock Inc. now owns 3,734,897 shares of the company’s stock valued at $71,076,000 after purchasing an additional 251,427 shares during the period. D. E. Shaw & Co. Inc. boosted its stake in shares of Tactile Systems Technology by 351.7% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 216,389 shares of the company’s stock valued at $4,118,000 after purchasing an additional 168,486 shares during the period. Cubist Systematic Strategies LLC purchased a new position in shares of Tactile Systems Technology in the fourth quarter valued at approximately $2,118,000. Finally, Morgan Stanley raised its holdings in Tactile Systems Technology by 23.8% in the second quarter. Morgan Stanley now owns 515,592 shares of the company’s stock valued at $26,812,000 after acquiring an additional 99,027 shares in the last quarter. Institutional investors own 98.59% of the company’s stock.
About Tactile Systems Technology (Get Rating)
Tactile Systems Technology, Inc, a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Featured Articles
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
Gloss